Dr. Guoyang Luo

Dr. Rodney McLaren is a specialty care physician board certified in obstetrics and gynecology, and maternal-fetal medicine. He joined Inova in 2025 and has been practicing since 1983. Prior to joining Inova, Dr. McLaren was the Medical Director of Metropolitan Maternal-Fetal Medicine, PC in Fairfax, VA. Dr. Mclaren is highly rated in 14 conditions, according to our data. His clinical expertise encompasses Gestational Diabetes, Fetal Edema, Hydrops Fetalis, Hemolytic Disease of the Newborn, and Hysterectomy. Dr. Mclaren is currently accepting new patients.

Dr. Ahmet Baschat is director of the Center for Fetal Therapy and professor in the Johns Hopkins Medicine Department of Gynecology and Obstetrics. His areas of clinical expertise include prenatal diagnosis and therapy of a wide range of fetal conditions including congenital diaphragmatic hernia, intrauterine growth restriction, twin-to-twin transfusion syndrome (TTTS), as well as other complications of monochorionic twin pregnancies. Dr. Baschat received his undergraduate and medical degrees from The Royal College of Surgeons in Ireland. He earned his doctorate in medicine (Dr. Med) from the University of Lübeck, where he also completed a residency in obstetrics and gynecology. Dr. Baschat also completed residencies at Newton-Wellesley Hospital and at University of Maryland Medical Center. He performed a fellowship in maternal-fetal medicine at University of Maryland Medical Center and went on to develop its Center for Advanced Fetal Care. Dr. Baschat joined the Johns Hopkins faculty in 2014. Prior to joining Johns Hopkins, Dr. Baschat was professor and director of Maternal-Fetal Medicine and the Section of Fetal Therapy at the University of Maryland School of Medicine. Dr. Baschat’s research interests include interventions and management techniques for fetal growth restriction and placental insufficiency. He has also done extensive research on the use of high resolution prenatal ultrasound techniques, including Doppler and fetal echocardiography, to predict and detect fetal complications. Dr. Baschat serves on a variety of boards and is a member of the American Congress of Obstetricians and Gynecologists (ACOG), the International Society of Ultrasound in Obstetrics & Gynecology and the International Fetal Medicine and Surgery Society. He has been recognized with several awards and honors, including the 2010 Award for Excellence in Research by the Society for Maternal-Fetal Medicine. Dr. Baschat’s passion for developing an individualized care plan for each of his patients has been the hallmark of his practice. Dr. Baschat is highly rated in 17 conditions, according to our data. His clinical expertise encompasses Twin-To-Twin Transfusion Syndrome, Intrauterine Growth Restriction, Bilateral Renal Agenesis Dominant Type, Diaphragmatic Hernia, and Endoscopy. Dr. Baschat is board certified in American Board Of Obstetrics And Gynecology. Dr. Baschat is currently accepting new patients.

Dr. Antonio Saad is the Maternal-Fetal Medicine Fellowship Program Director and Director of Perinatal Research Units at Inova Fairfax Medial Campus. He is a specialty care physician board certified in maternal-fetal medicine, critical care medicine, and obstetrics and gynecology. He joined Inova in 2023 and has been practicing since 2009. He is also a professor at University of Virginia School of Medicine. Prior to joining Inova, Dr. Saad was a critical care and maternal-fetal medicine physician, professor, Associate Maternal-Fetal Medicine Fellowship Program Director and Director of Clinical Research Division at the University of Texas Medical Branch in Galveston. Dr. Saad earned his medical degree from the American University of Beirut, followed by comprehensive training in critical care and maternal-fetal medicine at the University of Texas Medical Branch. He also obtained a master of business administration degree from the University of Houston C.T. Bauer College of Business, where he received the Dean's Award for Academic Excellence. Dr. Saad’s research has focused on pivotal issues such as critical care, cervical ripening, labor induction, amniotic fluid emboli, preeclampsia and obstetric hemorrhage. His efforts have been supported by numerous grants. Dr. Saad's career encompasses extensive experience in both clinical practice and academia. Before his current roles, he explored various facets of medicine, from postdoctoral research in cancer and autoimmune diseases to pharmaceutical sales. His expertise in critical care is further highlighted by his involvement in managing complex obstetric cases including sepsis, hemorrhage, trauma, and cardiac and hypertensive conditions in pregnancy. A distinguished editor of Critical Care Obstetrics and author of numerous book chapters, Dr. Saad has significantly contributed to the literature in obstetrics and gynecology. His work in developing guidelines and educational materials for both healthcare professionals and patients showcases his commitment to advancing healthcare standards. Dr. Saad's scholarly contributions extend to peer-reviewed articles on a wide range of topics within his field. He has been recognized for excellence in mentorship and teaching through awards such as the OB-GYN Golden Apple Award and the Society of Maternal-Fetal Medicine Award of Research Excellence. At Inova Fairfax Medical Campus and the University of Virginia School of Medicine, Dr. Saad continues to lead by example, blending his clinical expertise in critical care with his academic pursuits to foster a safer, more effective approach to maternal-fetal medicine. Dr. Saad is highly rated in 10 conditions, according to our data. His clinical expertise encompasses Preeclampsia, Gestational Diabetes, Newborn Low Blood Sugar, Salpingo-Oophorectomy, and Hormone Replacement Therapy (HRT). Dr. Saad is currently accepting new patients.